Ultra-fast insulin drug Fiasp to be removed from PBS making it unaffordable for many diabetes sufferers

ABC News

2 March 2023 - For the past six months, 14-year-old Freya Goldston has attended more school, swimming training and increased her time with friends — but that quality of life is now at risk.

Fiasp, the ultra-fast insulin she relies on to treat her type 1 diabetes will be taken off the Pharmaceutical Benefits Scheme (PBS) next month, sending the price soaring.

Read ABC News article

Michael Wonder

Posted by:

Michael Wonder